Adhesion molecule expression in experimental myositis

Area of Science:

• Immunology
• Pathology
• Molecular Biology

Background:

• Experimental allergic myositis (EAM) in Lewis rats, induced by myosin, serves as a key model for human polymyositis.
• Understanding the role of adhesion molecules is vital for elucidating the pathogenesis of autoimmune muscle inflammation.

Purpose of the Study:

• To investigate the intramyosial expression of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in EAM rats.
• To determine the serum levels of soluble ICAM-1 during the course of EAM.
• To clarify the role of these adhesion molecules in the initiation of myositis.

Main Methods:

• Induction of EAM in Lewis rats using partially purified myosin.
• Immunohistochemical analysis of ICAM-1 and VCAM-1 expression in muscle tissues.
• Measurement of serum soluble ICAM-1 levels.
• Correlation of adhesion molecule levels with histological inflammatory scores.

Main Results:

• Significant upregulation of ICAM-1 and VCAM-1 was observed in the endothelium of muscle vessels, inflammatory infiltrates, and on muscle fibers in EAM rats.
• Serum and muscle extract levels of ICAM-1 increased, peaking early after immunization and correlating with inflammatory lesion severity.
• These adhesion molecules were notably elevated in the early stages of EAM development.

Conclusions:

• Increased expression of ICAM-1 and VCAM-1 occurs during the early phase of experimental allergic myositis.
• These adhesion molecules likely play a significant role in the initiation and progression of the inflammatory process in myositis.
• Targeting adhesion molecules may offer therapeutic potential for autoimmune myopathies.